Clonidine HCL
1R21DA016288-01A1
Phase 3 small_molecule completed
Quick answer
Clonidine HCL for Neonatal Abstinence Syndrome is a Phase 3 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 2 ClinicalTrials.gov record(s).
Program details
- Company
- BRIGHT MINDS BIOSCIENCES INC.
- Indication
- Neonatal Abstinence Syndrome
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed